Spirepoint Private Client, LLC Merck & Co., Inc. Transaction History
Spirepoint Private Client, LLC
- $798 Billion
- Q4 2024
A detailed history of Spirepoint Private Client, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 68,443 shares of MRK stock, worth $5.97 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
68,443
Previous 22,037
210.58%
Holding current value
$5.97 Million
Previous $2.5 Billion
172.07%
% of portfolio
0.85%
Previous 0.33%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,855Shares Held
1.89BCall Options Held
15.5MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA250MShares$21.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.4 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.62 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.16 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $221B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...